Doximity Inc

For the period ended Mar 31, 2024. Filed May 23, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed May 23, 2024

DOCS$32.87+1.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(in thousands, except per share data)

	Fiscal Year Ended March 31,
	2024	2023	2022
Revenue	$475,422	$419,052	$343,548
Cost of revenue	50,669	53,490	39,787
Gross profit	424,753	365,562	303,761
Operating expenses:
Research and development	81,983	80,186	62,350
Sales and marketing	133,129	123,523	92,129
General and administrative	37,827	36,745	35,746
Restructuring	7,936	—	—
Total operating expenses	260,875	240,454	190,225
Income from operations	163,878	125,108	113,536
Other income, net	21,324	8,048	469
Income before income taxes	185,202	133,156	114,005
Provision for (benefit from) income taxes	37,620	20,338	(40,778)
Net income	$147,582	$112,818	$154,783
Undistributed earnings attributable to participating securities	—	—	(21,526)
Net income attributable to Class A and Class B common stockholders, basic and diluted	$147,582	$112,818	$133,257
Net income per share attributable to Class A and Class B common stockholders:
Basic	$0.78	$0.58	$0.82
Diluted	$0.72	$0.53	$0.70
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic	190,172	193,176	163,484
Diluted	205,734	213,425	191,017

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.